Avanos Medical, Inc.
General ticker "AVNS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $616.1M (TTM average)
Avanos Medical, Inc. does not follow the US Stock Market performance with the rate: -2.6%.
Estimated limits based on current volatility of 1.6%: low 12.89$, high 13.30$
Factors to consider:
- Total employees count: 2227 (-40.9%) as of 2024
- US accounted for 76.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Pandemic risks, Market competition, Supply chain disruptions, Economic downturns and volatility, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.40$, 19.55$]
- 2025-12-31 to 2026-12-31 estimated range: [10.16$, 18.98$]
Financial Metrics affecting the AVNS estimates:
- Positive: with PPE of 11.9 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 13.64 > 12.99
- Positive: -5.04 < Operating profit margin, % of 5.82
- Negative: Investing cash flow per share per price, % of -3.73 <= -0.63
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 71.78 > 64.37
- Negative: negative Industry operating income (median)
Short-term AVNS quotes
Long-term AVNS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $681.10MM | $660.00MM | $687.80MM |
| Operating Expenses | $645.60MM | $655.80MM | $647.80MM |
| Operating Income | $35.50MM | $4.20MM | $40.00MM |
| Non-Operating Income | $-8.80MM | $-12.10MM | $-443.30MM |
| Interest Expense | $10.00MM | $15.00MM | $12.20MM |
| R&D Expense | $29.20MM | $27.20MM | $26.20MM |
| Income(Loss) | $26.70MM | $-7.90MM | $-403.30MM |
| Taxes | $5.20MM | $2.00MM | $-17.00MM |
| Other Income(Loss) | $29.00MM | $-51.90MM | $0.00MM |
| Profit(Loss)* | $79.50MM | $-113.70MM | $-392.10MM |
| Stockholders Equity | $1,291.20MM | $1,236.30MM | $828.50MM |
| Inventory | $132.30MM | $163.20MM | $138.80MM |
| Assets | $1,786.90MM | $1,692.40MM | $1,154.20MM |
| Operating Cash Flow | $90.90MM | $32.40MM | $100.70MM |
| Capital expenditure | $19.30MM | $17.80MM | $17.80MM |
| Investing Cash Flow | $-135.40MM | $21.60MM | $-27.50MM |
| Financing Cash Flow | $56.70MM | $-94.20MM | $-49.10MM |
| Earnings Per Share** | $1.70 | $-2.44 | $-8.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.